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Influenza virus entry occurs in endosomes, where acidification triggers irreversible conformational changes of the hemagglutinin glycoprotein
(HA) that are required for membrane fusion. The acid-induced HA structural rearrangements have been well documented, and several models have
been proposed to relate these to the process of membrane fusion. However, details regarding the role of specific residues in the initiation of
structural rearrangements and membrane fusion are lacking. Here we report the results of studies on the HA of A/Aichi/2/68 virus (H3 subtype), in
which mutants with changes at several ionizable residues in the vicinity of the “fusion peptide” were analyzed for their effects on the pH at which
conformational changes and membrane fusion occur. A variety of phenotypes was obtained, including examples of substitutions that lead to an
increase in HA stability at reduced pH. Of particular note was the observation that a histidine to tyrosine substitution at HA1 position 17 resulted
in a decrease in pH at which HA structural changes and membrane fusion take place by 0.3 relative to WT. The results are discussed in relation to
possible mechanisms by which HA structural rearrangements are initiated at low pH and clade-specific differences near the fusion peptide.
© 2007 Elsevier Inc. All rights reserved.Keywords: Influenza; Hemagglutinin; Membrane fusion; Fusion peptide; HA structure; Conformational changeIntroduction
Membrane fusion is a biological process required for a
variety of fundamental viral and cellular functions. Develop-
ments in recent years have significantly expanded the
understanding of the fusion mechanisms for both class I and
class II viral fusion glycoproteins (Barnard et al., 2006; Colman
and Lawrence, 2003; Doms, 2004; Dutch et al., 2000; Earp
et al., 2005; Eckert and Kim, 2001; Harrison, 2005; Huang
et al., 2003; Kielian, 2006; Lamb et al., 2006; Sieczkarski and
Whittaker, 2005; Skehel and Wiley, 2000; Smith and Helenius,
2004). Among the class I viral fusion proteins, related mech-
anisms for fusion have evolved in which a metastable form of
the molecule is converted into a highly thermostable confor-⁎ Corresponding author. Fax: +1 404 727 3659.
E-mail address: steinhauer@microbio.emory.edu (D.A. Steinhauer).
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doi:10.1016/j.virol.2007.08.035mation during the fusion process. These thermostable struc-
tures are rod-like in appearance and all contain a central
trimeric α-helical coiled coil and antiparallel polypeptide
chains that pack against it. As a consequence of the refolding
events, the hydrophobic transmembrane and fusion peptide
domains of the glycoproteins, which are postulated to associate
with the viral and cellular membranes, respectively, as part of
the fusion process, are brought into close proximity with one
another. For the class I viral fusion proteins, there are a number
of mechanisms by which such conformational changes can be
triggered to initiate the fusion process. These include receptor
binding with the involvement of coreceptors, receptor binding
and interaction with separate viral fusion proteins, and
activation of a viral fusion protein by acidification following
endocytosis.
Influenza A is a well-characterized example of a virus that
enters the host cell via the endocytic pathway, and structural
studies spanning the past three decades have made the HA
Fig. 1. Superimposed ribbon diagrams of uncleaved HA0 (green) and cleaved
HA (yellow), which deviate only at positions 323–329 of HA1 and 1–12 of
HA2. To highlight the structural relocations that occur upon cleavage, for two of
the monomers, the positions of the C-termini of HA1 and the N-termini of HA2
are indicated by red and blue balls respectively. The structure of uncleaved HA0
is also shaded to indicate van der Waals radii. This highlights the loop structure
of HA0 and the central cavity into which the N-terminal portion of the HA2
fusion peptide relocates following cleavage.
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fusion in general (Bullough et al., 1994; Chen et al., 1998;
Wilson et al., 1981). Similar to other class I viral fusion pro-
teins, the polypeptide chains of the HA precursor (HA0)
associate as homotrimers in the endoplasmic reticulum during
biosynthesis. Each monomer of HA0 is subsequently cleaved at
a surface loop into the disulfide-linked polypeptides HA1 and
HA2. This generates hydrophobic HA2 N-terminal fusion
peptide domains and transforms the molecule into its metastable
conformation to activate the membrane fusion potential of
HA. As a consequence, HA0 cleavage is required for virus
infectivity (Appleyard and Maber, 1974; Klenk et al., 1975;
Lazarowitz and Choppin, 1975). After attachment to host cells
and internalization, HA undergoes irreversible conformational
changes due to the acidification of the endosomal environment,
and membrane fusion is induced.
The current study focuses on the analysis of residues near the
fusion peptide of cleaved HA that may be involved in the
initiation of the acid-induced HA conformational changes re-
quired for fusion. While it is known that amino acid substi-
tutions at various locations in the HA trimer are capable of
destabilizing the native structure leading to an increase in the
pH of fusion, the possibility that protonation of specific resi-
dues provide the initial trigger for conformational changes
remains unresolved. The region surrounding the fusion peptide
in the native HA structure is of interest regarding potential
triggers for fusion for several reasons. Among the many
mutants with elevated fusion pH identified in studies based on
amantadine resistance, site-directed mutagenesis, and reverse
genetics, those involving amino acid substitutions in and
around the fusion peptide are particularly well represented
(Cross et al., 2001; Daniels et al., 1985; Lin et al., 1997; Stein-
hauer et al., 1993). In fact, nearly all amino acid substitutions in
the N-terminal region of the fusion peptide that have been
analyzed to date lead to increased fusion pH, regardless of the
HA position or the amino acid introduced (Cross et al., 2001;
Gething et al., 1986; Steinhauer et al., 1995). Studies on double
mutant HAs also indicate that amino acid substitutions in and
around the fusion peptide are dominant in dictating the pH of
fusion when expressed in combination with substitutions
elsewhere in the molecule (Steinhauer et al., 1996). Other
studies using anti-peptide antibodies to detect changes in HA
structure also suggest that conformational changes involving
the fusion peptide and proximal residues precede the de-
trimerization of the HA1 head domains (White and Wilson,
1987).
When HA0 is cleaved into HA1 and HA2 to prime membrane
fusion potential, only six residues at the C-terminus of HA1 and
12 residues at the N-terminus of HA2 are relocated (Chen et al.,
1998) (Fig. 1 ). As the conformational changes that accompany
cleavage are restricted to this region, the accessibility to solvent
is altered for only a selected number of ionizable residues in the
trimer. A comparison of the structures of different subtype HAs
shows that some of the ionizable residues that are buried by the
fusion peptide after cleavage are completely conserved, while
others vary strictly along clade-specific lines (Gamblin et al.,
2004; Ha et al., 2002; Russell et al., 2004; Wilson et al., 1981).The recently determined H13 subtype HA structure (Russell et
al., unpublished) now divides the HAs into five clades, and when
structural characteristics of the fusion peptide region are com-
pared the five clades can be separated into two groups as
depicted in Fig. 2. The H1 group includes H1-, H9-, and H13-
like viruses, and the H3 group includes the H3 and H7 clades. In
all HAs HA2 residues K51, D109, and D112 are completely
conserved, whereas the residues at positions HA1 17, and HA2
106, and 111 are group specific. Among H3 group HAs, such as
the Aichi HA analyzed in this study, HA1 17 and HA2 106 are
nearly always histidine, and HA2 111 is threonine. In the H1
group HAs, HA1 17 is tyrosine, HA2 111 is histidine, and HA2
106 is either a basic lysine or arginine residue (Fouchier et al.,
2005; Kawaoka et al., 1990; Nobusawa et al., 1991; Rohm et al.,
1996).
We postulate that these residues are involved in modulating
the stability of cleaved HA, and that the introduction of
substitution mutations at these positions will have a tendency
to alter the pH at which conformational changes are induced.
Changes to positions that result in increased stability (reduced
pH of fusion) could possibly help identify residues that are
involved in the triggering of conformational changes when
protonated. To examine the possible role of specific residues in
the initiation of fusion upon acidification, we generated a
series of single, double, and triple amino acid substitution
mutants in an H3 subtype HA. The mutant HAs were analyzed
for folding, cell-surface transport, acid-induced structural
changes, the pH at which they take place, and membrane
fusion properties. A variety of phenotypes were detected, in-
cluding examples that undergo conformational changes and
mediate membrane fusion at reduced pH. A possible role for
particular ionizable residues in the initiation of the fusion
process is discussed. Furthermore, we compare the structures
of this region among HA subtypes and discuss clade-specific
differences with regard to acid-induced activation of mem-
brane fusion.
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A series of single, double, and triple amino acid substitution
mutants were constructed in the HA of A/Aichi/2/68 virus at
position 17 of the HA1 subunit and at positions 51, 105, 106,
109, 111, and 112 of the HA2 subunit, and recombinant vaccinia
viruses were generated for their expression. The structural
locations of these positions are indicated in Fig. 2. These include
residues that become occluded from access to bulk solvent
following cleavage of HA0 and transition to the metastable
neutral pH conformation. For these, the chemical environment
and potential for protonation may change following cleavageFig. 2. The top panel shows a phylogenetic tree showing the HA subtype clades as d
divided into the H1 and H3 groups based in part on structural considerations in the fus
H1, and H9 HAs focusing on the region near the fusion peptide. The HA2 N-termini
indicated and the three positions that segregate in clade-specific groupings, HA1 17, H
based on the H3 subtype).activation of HA. The mutants that were analyzed involved
alanine substitutions, and changes in which the ionization
properties of side chains were altered using amino acids of
similar dimension. In addition, we made mutants in which the
residues of the H3 HA at positions 17 of HA1 and positions 105,
106, and 111 of HA2 were exchanged for residues at the
equivalent structural locations in the H1 group HAs.
Cell surface expression by ELISA
The mutants that were generated and analyzed in this study
are listed in Table 1, along with ELISA data for antibodyefined by sequence and structural analyses (Russell et al., 2004). The clades are
ion peptide region. Panels at the bottom show a structural comparison of H3, H7,
are labeled by colored balls. The locations of residues addressed in this study are
A2 106, and HA2 111, are labeled in bold font (all HA numbering in this paper is
Fig. 3. Cell surface expression of HAs as assayed by trypsin cleavage of HA0
into HA1 and HA2. Recombinant vaccinia virus-infected HA-expressing cell
monolayers were incubated with or without trypsin and cell lysates were
analyzed by western blot following SDS–PAGE under reducing conditions.
Table 1
Antibody reactivity of cell-surface HAs by ELISA (% WT)
HA HC3 HC31 HC67 HC68 HC100 HC263 α-X31
WT 100 100 100 100 100 100 100
H171A 100 85 99 82 105 81 104
H171Y 102 98 108 90 113 83 101
K512A 109 99 98 84 106 96 106
K512E 104 75 85 89 98 82 101
Q1052A 109 99 96 88 105 98 104
Q1052E 111 98 97 93 110 99 108
H1062A 106 113 102 100 107 93 105
H1062F 106 98 84 92 98 95 108
H1062R 99 78 99 85 106 83 112
D1092A 102 105 104 98 103 88 107
T1112A 110 125 104 105 117 99 105
T1112H 100 70 89 86 107 77 106
T1112V 99 78 81 88 101 88 109
D1122A 98 107 99 104 105 88 105
H1062A, T1112A 98 92 103 92 109 76 104
H1062F, T1112V 96 75 73 85 89 79 95
H1062R, T1112H 96 27 35 48 84 31 96
D1092A, D1122A 21 16 8 22 26 14 38
H171A, H1062A,
T1112A
91 47 43 54 85 33 94
H171Y, H1062A,
T1112A
100 98 104 87 107 81 107
H171Y, H1062R,
T1112H
102 31 12 27 91 23 96
Values represent averages derived from a minimum of three separate
experiments.
Table 2
Overview of HA mutant expression results
HA Expression characteristics a
WT, all single mutants,
(H1062A, T1112A),
(H1062F, T1112V), and
(H171Y, H1062A, T1112A)
ELISA—react with
non-specific antibodies, react with
conformation-specific antibodies
Trypsin cleavage—HA0 cleaved,
HA1 generated, HA2 generated
Interpretation—HA expressed on cell
surface in native neutral pH conformation
(H1062R, T1112H),
(H171A, H1062A, T1112A), and
(H171Y, H1062R, T1112H)
ELISA—react with non-specific
antibodies, reduced reactivity with
conformation-specific antibodies
Trypsin cleavage—HA0 doublet (CHO?)
cleaved, HA1 degraded, HA2 generated,
also present in small quantities
without trypsin treatment
Interpretation—HA expressed on cell
surface in non-native conformation,
possibly resembling the low pH structure
(D1092A, D1122A) ELISA—poor reactivity to all antibodies
Trypsin cleavage—HA0 bands only,
with or without trypsin
Interpretation—HA does not fold
correctly or is very unstable, degraded
in the ER or during transport to
the cell surface
a Comments and interpretations based on Table 1 and Fig. 3.
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clonal antibodies and a rabbit polyclonal antiserum were used to
assess HA expression and protein folding following infection of
HeLa cell monolayers with recombinant vaccinia viruses. The
monoclonal antibodies utilized are known to bind to a range of
sites on the HA structure based on the locations of changes
mapped in neutralization-resistant virus mutants (Daniels et al.,
1983) and electron microscopy and X-ray crystallography
studies of HA-antibody complexes (Bizebard et al., 2001;
Wrigley et al., 1983). The monoclonal antibodies HC3 and
HC100 recognize the neutral as well as the low pH conformation
of HA. The other monoclonal antibodies are specific for the
neutral pH structure of HA but lose reactivity as a result of acid-
induced HA conformational changes. The α-X31 antibody is a
rabbit polyclonal serum raised against the bromelain-solubilized
ectodomain (BHA) of the WT HA of A/Aichi/2/68 virus.
Table 1 shows the data for expression of the mutants as a
percentage of the WT reactivity (designated as 100%). The data
show that with the exception of the double and triple mutants
(H1062R, T1112H), (D1092A, D1122A) (H171A, H1062A,
T1112A), and (H171Y, H1062R, T1112H), all mutants reacted
with the antibodies at levels similar to WT HA (subscripts
denote the HA polypeptide). Of these, the mutant (D1092A,
D1122A) reacted poorly with all of the monoclonal antibodies
and the polyclonal serum, indicating that it is probably not
transported to the cell surface. The other three reacted well only
with the antibodies that recognize both the native and low pH
conformations of HA (HC3, HC100, and the polyclonal serum),
but not the neutral pH-specific antibodies, indicating that theyexpress at the cell surface in conformations that are more
characteristic of low pH HA than the neutral pH structure.
Analysis of cell surface expression by trypsin susceptibility
Influenza HA is expressed at the surface of recombinant
vaccinia virus-infected cells in its uncleaved precursor form.
Therefore, cleavage of HA0 into the HA1 and HA2 polypeptides
by trypsin treatment of HA-expressing cell monolayers can be
Fig. 4. Graphs of ELISA data showing the pH of conformational change for various mutant and WT HAs. Graphs plot the ratios of HC67/HC3 reactivity as a function of pH. HC67 binds well with neutral pH HA, but
poorly to the low pH structure. HC3 binds equally well with both HA conformations.
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Table 3
Summary of mutant data on ΔpH of conformational change relative to WT
ΔpH a
ELISA Trypsin Polykaryon Average
H171A +0.4 +0.4 +0.4 +0.4
H171Y −0.3 −0.4 −0.3 −0.3
K512A −0.3 −0.1 −0.1 −0.2
K512E −0.2 −0.1 −0.1 −0.1
Q1052A −0.2 0.0 0.0 −0.1
Q1052E −0.1 +0.1 +0.1 0.0
H1062A +0.1 +0.2 +0.1 +0.1
H1062F −0.1 −0.1 −0.2 −0.1
H1062R −0.1 +0.1 0.0 0.0
D1092A +0.2 +0.4 +0.3 +0.3
T1112A +0.1 0.0 +0.1 +0.1
T1112H +0.6 +0.6 +0.6 +0.6
T1112V +0.3 +0.3 +0.3 +0.3
D1122A +0.5 +0.5 +0.5 +0.5
H1062A, T1112A +0.4 +0.4 − b +0.4
H1062F, T1112V +0.4 +0.4 +/− c +0.0
H171Y, H1062A, T1112A +0.1 0.0 +0.1 +0.1
a The values given for each assay represent the average from aminimumof three
experiments. In all cases, the range among replicates was less than 0.1 pH units.
b No polykaryon formation detected at any pH.
c Only low levels of fusion detected, and only at pH 0.1 or more lower than
WT.
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the characteristic migration patterns of the trypsin cleavage
products following polyacrylamide gel electrophoresis under
reducing conditions can provide an indicator that the HA is
folded properly in the native conformation. Fig. 3 shows a
western blot analysis of WT and mutant HA-expressing cell
lysates processed following the incubation of monolayers with
or without trypsin. The results reveal that WT HA and all single
residue substitution mutants can be cleaved into HA1 and HA2
polypeptides of characteristic size, confirming that they are
expressed at the cell surface. Digestion of the double mutants
(H1062A, T1112A) and (H1062F, T1112V) and the triple mutant
(H171Y, H1062A, T1112A) also yielded HA1 and HA2 poly-
peptides that resembled in size those of WT HA, although the
(H1062F, T1112V) HA2 band migrated as a doublet containing
an additional product of lower apparent molecular weight. On
the other hand, the results obtained following trypsin treatment
of the double mutants (H1062R, T1112H) and (D1092A,
D1122A), and the (H171A, H1062A, T1112A) and (H171Y,
H1062R, T1112H) triple mutants differed significantly from
those observed with WT HA. The (D1092A, D1122A) HA blot
revealed only low intensity bands corresponding to HA0, with or
without added trypsin. Presumably, this HA does not fold
correctly or express on the cell surface, as suggested by the lack
of reactivity to any sera by ELISA in experiments described
above. The other three mutant HAs, (H1062R, T1112H), (H171A,
H1062A, T1112A), and (H171Y, H1062R, T1112H), produce
bands corresponding to HA2 in molecular weight following
trypsin digestion, but no HA1 bands can be detected. For these
mutants, a slower migrating HA0 component is observed in the
absence of added protease, suggesting aberrant glycosylation
properties. The ELISA results described above demonstrate that
polyclonal sera and antibodies that recognize both neutral and
low pHHA can effectively bind these three mutant HAs, but they
are recognized poorly with the neutral pH-specific antibodies.
Taken together, the results of the two assays suggest that these
mutants are likely to be transported to the cell surface in an
altered conformation, perhaps resembling the low pH structure.
The results and our interpretations of the ELISA and cell surface
trypsin cleavage experiments are summarized in Table 2.
Analysis of the pH of conformational change by ELISA
Antibody HC3 recognizes residues located in a surface loop
that does not change structure when HA is acidified (Bizebard
et al., 1995; Wiley and Skehel, 1987) and therefore reacts well
with both the neutral and low pH structures of HA. On the other
hand, HC67 recognizes an antigenic site at a membrane distal
trimeric interface that is lost when the HA head regions de-
trimerize at low pH. Consequently, pH adjustment of HA-
expressing cells followed by ELISA to compare the reactivity of
these two antibodies can be used to estimate the pH at which
conformational changes take place. Fig. 4 shows the ELISA
results for the single amino acid HA substitution mutants
presented in graph form plotting the ratio of HC67 to HC3
reactivity as a function of pH. The midpoint of the curves shown
in Fig. 4 is designated as the pH of conformational change andthe differences between these determinations for mutant HAs
compared toWT (theΔpH of conformational change) are shown
as a component of Table 3. Several of the mutant HAs dem-
onstrated a significantly elevated pH of conformational change,
while others appeared more acid-stable. Most notable amongst
the latter were the HA1 H17Y and the HA2 K51A mutants,
which were observed to undergo conformational changes at a pH
0.3 lower than WT (pH 4.9 vs. pH 5.2).
Analysis of the pH of conformational change by trypsin
susceptibility
Once HA0 has been cleaved into HA1 and HA2, the neutral
pH structure is highly resistant to further proteolytic digestion
by trypsin and several other proteases. However, the molecular
rearrangements induced by acidification render the HA1 subunit
susceptible to digestion by trypsin (Skehel et al., 1982).
Therefore, we used trypsin susceptibility as an alternative
assay to determine the pH at which the structural changes take
place for mutant HAs. CV1 cells were infected with recom-
binant vaccinia viruses and the HA-expressing cell monolayers
were trypsin treated to cleave HA0, the pH was adjusted in
decreasing increments of 0.2, and HA digestion was analyzed
following a second trypsin digestion. Cell lysates were then
processed using reducing conditions and analyzed by western
blot. The digestion profiles for a selection of the HAs as a
function of pH are shown in Fig. 5. Band intensities were
quantified to estimate the pH of HA1 digestion as an indicator
of the pH of conformational change, and the ΔpH values
relative to WT are shown in Table 3. Overall, the results are in
general agreement with those obtained by ELISA, with only a
few examples of minor variation in the values obtained forΔpH
of conformational change.
Fig. 5. Western blot analysis for the determination of the pH of conformational change by trypsin susceptibility. HA expressing cells were treated with trypsin to cleave
HA0, washed, pH was adjusted as indicated, and monolayers were again treated with trypsin. Lysates were then analyzed by western blot following SDS–PAGE under
reducing conditions. The digestion of HA1 bands is indicative of the pH of conformational change.
Fig. 6. Polykaryon formation by HA-expressing BHK cells following incubation at the indicated pH.
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Fig. 7. Overlapping structural representation of H1 and H3 subtype HAs in the
region of the fusion peptide. Fusion peptides are shown in yellow and long
helices in red. Dashed lines indicate hydrogen bonds. A single H-bond to the
fusion peptide is formed by D109 in each HA (two shown, one for each HA
subtype). Residue D112 forms four H-bonds in each case. The position of HA1
His17 in the H3 HA is shown in green and the Tyr at the equivalent position in
H1 HAs is shown in blue. The two direct H-bonds formed by Tyr to main chain
oxygen of fusion peptide residues 10 and 12 are indicated.
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formation
The fusion properties of recombinant vaccinia virus-infected
cells expressing WT or mutant HAs were analyzed using an
assay for polykaryon formation. BHK-21 cells were infected
with recombinant vaccinia viruses, trypsin treated, the pH was
reduced incrementally from one well to the next, and the pH of
monolayers was neutralized. Cells were then incubated in
complete medium and monitored for evidence of fusion by light
microscopy. The results of polykaryon formation as a function
of pH are shown for selected mutants in Fig. 6, and the ΔpH
results for all mutants are summarized in Table 3. The results for
pH of polykaryon formation are consistent with those obtained
by ELISA and trypsin susceptibility for pH of conformational
change. The only clear discrepancy involved the double mutants
at HA2 positions 106 and 111. The (H1062A, T1112A) and
(H1062F, T1112V) mutants were both observed to undergo
structural changes at pH 0.4 above WT, but in both cases the
capacity to mediate polykaryon formation was found to be
inhibited. No fusion activity was observed with (H1062A,
T1112A) HA-expressing cells, and with cells expressing the
(H1062F, T1112V) mutant, low levels of polykaryon formation
were detected only at pH 0.1 or more below WT HA. HA2
residues 106 and 111 are at the ends of the peptide segment of
the neutral pH coiled coil that undergoes a helix-to-loop
transition upon acidification. Therefore, the changes at these
positions may affect this particular molecular rearrangement or
the formation of a low pH structure that is optimal for fusion in
addition to causing decreased stability of HA and increased pH
of conformational change as detected by ELISA and trypsin
assays. No fusion activity was detected for trypsin-treated non-
recombinant vaccinia viruses, or for non-trypsin-treated HA-
expressing cells (data not shown). The results demonstrate that
relative to WT HA, the pH of fusion as measured by polykaryon
formation is consistent with the ΔpH data obtained using the
conformational change assays (Table 3).
Discussion
A number of HA mutants that undergo acid-induced confor-
mational changes and mediate membrane fusion at elevated
pH have been reported (Cross et al., 2001; Daniels et al., 1985;
Doms et al., 1986; Gething et al., 1986; Lin et al., 1997;
Steinhauer et al., 1993, 1995). The mutations responsible for
this phenotype have been mapped to various locations
throughout the length of the trimer, where they generally reside
at interfaces between monomers, at HA1 and HA2 subunits
within a monomer, or at regions between adjacent domains
within a monomer that rearrange upon acidification. Presum-
ably, such mutations cause localized changes between domains
that rearrange during fusion, and destabilize the overall
structure of the neutral pH HA.
The results reported here involve mutant HAs with changes
at positions that reside in the vicinity of the fusion peptide of
neutral pH HA which become altered with respect to solvent
accessibility and chemical environment as a result of HA pre-cursor cleavage. Compared to cleaved HA, the HA0 precursor is
unresponsive to decreases in pH based on the assays described
here, suggesting that changes in environment or newly formed
contacts involving these residues may be critical for the induc-
tion of fusion. A total of 21 single, double, or triple mutant HAs
were analyzed and a variety of phenotypes were observed with
respect to the pH of acid-induced conformational changes and
membrane fusion properties.
Among the residues chosen for analysis here were HA2 Asp
109, Asp 112, and Lys 51, which are completely conserved
among all HA subtypes. Individual alanine substitutions for
aspartic acid residues at HA2 positions 109 and 112 were found
to increase the pH of fusion by 0.3 and 0.5, respectively. These
results are in agreement with previous reports regarding the
mutants D1092G, D1092E, D1122G, D1122E, and D1122N,
which also lead to elevated fusion pH (Daniels et al., 1985;
Hoffman et al., 1997; Steinhauer, 1992, 1996). In WT HA
D1092 forms hydrogen bonds to Q1052 via a water molecule
and also hydrogen bonds to the main chain amide group of
residue 2 of the fusion peptide. The carboxylate oxygens of WT
residue D1122 form four hydrogen bonds with the amide
nitrogens of HA2 residues 3, 4, 5, and 6. The five hydrogen
bonds formed by these aspartic acids to the fusion peptide are
present in all HAs analyzed as illustrated for H1 and H3 subtype
HAs in Fig. 7. Presumably, these interactions with the fusion
peptide are important for stabilizing the neutral pH structure.
Our results suggest that the additive effects created by double
mutation (D1092A, D1122A) destabilize HA to such an extent
that its folding and transport to the cell surface is prohibited.
HA2 position 51 is situated near the middle of the shorter of
the two prominent α-helices of the neutral pH HA hairpin
411S. Thoennes et al. / Virology 370 (2008) 403–414structure. In all HAs, the conserved lysine side chain of HA2 51
is positioned similarly, extending into the solvent-occluded
cavity towards HA2 residue 106 (Fig. 2). In the H3 group HAs,
HA2 106 is usually histidine, which forms a hydrogen bond
with HA2 Lys 51. In H1 group HAs, HA2 106 is either lysine or
arginine, with the side chains oriented away from HA2 Lys 51.
When HA2 106 is Arg, a hydrogen bond with HA2 Asp 109 of
the adjacent monomer is formed (Russell et al., 2004). Our
results with alanine and glutamic acid substitutions for HA2 Lys
51 indicate that these changes stabilize the neutral pH structure
to some extent. Perhaps this results from the loss of repulsive
interactions between this K512 and H1062 side chains that may
develop during acidification (see Fig. 2). This interpretation is
consistent with results obtained with the HA2 106 His-to-Phe
mutant, which also results in a marginal decrease in fusion pH.
However, this effect is not observed with mutant HAs
containing substitution of arginine or alanine at HA2 106,
possibly due to other structural constraints.
Although it is not an ionizable residue, HA2 Gln 105 was
chosen for analysis due to its position in the structure and based
on phylogenetic considerations. Glutamine is present at this
position in the H3 group HAs, and also in H9 clade HAs,
whereas in other subtypes there is an acidic residue (usually
glutamic acid). This is notable because for other positions in this
region containing residues that segregate along group-specific
lines, the H9 clade HAs fall into the H1 group (Fig. 2). In WT
H3 HAs, the glutamine at HA2 position 105 forms a hydrogen
bond with the amide nitrogen of HA1 residue 29 and has van
der Waals contact with HA2 His 106 from an adjacent mono-
mer, as well as forming hydrogen bonds to HA2 Asp 109 via
water. Previously, a Q1052R mutation was shown to elevate
fusion pH by 0.3, possibly by forming a salt bridge with the
aspartic acid side chain of HA2 109 and altering its interactions
with the fusion peptide. In the examples reported here, the
glutamic acid substitution appears to have little effect on fusion
pH when taking all three assays into consideration. However,
the ELISA results in particular, suggest that an alanine
substitution at HA2 position 105 may stabilize the structure of
neutral pH HA to a small degree, possibly due to the packing of
its methyl side chain against the hydrophobic isoleucine at HA1
position 29.
The most provocative of the residues analyzed here with
respect to the induction of acid-induced conformational changes
and membrane fusion involve positions HA1 17, and HA2
positions 106 and 111. These are conserved along group-specific
lines, and the presence or absence of histidine residues at these
positions may be significant for triggering fusion. As a result of
HA0 cleavage, the solvent-accessible histidine HA1 residue 17
becomes completely buried by the relocation of the fusion
peptide into the trimer interior. Upon acidification, the newly
formed contacts made by residue 17 in the cleaved HA are then
lost and the fusion peptide is extruded as part of the fusion
process. HA2 residues 106 and 111 are in a short segment of the
long central helix of neutral pH HA that undergoes a helix-to-
loop transition following acidification. This component of the
conformational changes is critical for the fusion process as it is
necessary to allow the C-terminal portion of HA to reorient by180° to pack against the newly elongated central coiled coil of
low pH HA. This jackknife action leads to the formation of the
rod-like structure that contains the hydrophobic transmembrane
and fusion peptide domains at one end and the HA2 106 and 111-
containing loop at the other. In H3 group HAs, HA1 17 and HA2
106 and 111 are typically His, His, and Thr, respectively. By
contrast, in H1 group HAs the residues at these three positions
are characteristically Tyr, either Arg or Lys, and His.
In the studies reported here, the histidine to arginine sub-
stitution at HA2 106 essentially had no effect on the HA fusion
pH phenotype. An alanine substitution at this position caused a
slight increase in fusion pH, whereas the phenylalanine mutant
at HA2 106 resulted in a reduction of between 0.1 and 0.2 in
the pH at which conformational changes and polykaryon
formation were observed. These results are likely to be due to
interactions involving residues HA2 51, 105, and 109 as
discussed above.
The results of mutations at HA1 position 17 indicate that this
histidine residue may play a critical role in the initiation of
membrane fusion for HAs of H3 group viruses. As discussed
earlier, this is one of the group-specific residues that is almost
completely buried due to the relocation of the fusion peptide
following cleavage. In the neutral pH HA, residue 17 forms
hydrogen bonds via a water molecule to carbonyl oxygen of
HA2 residues 6 and 10, and also hydrogen bonds with HA1 His
18 (Daniels et al., 1985). In the H1 group HAs, this residue is
tyrosine. Previous studies with H3 subtype HAs have shown that
substitution of HA1 His 17 with arginine or glutamine results in
an increase of between 0.7 and 0.9 in the pH of membrane fusion
(Daniels et al., 1985; Rott et al., 1984; Steinhauer et al., 1996;
Wharton et al., 1986), which makes them among the least stable
HAs that have been observed in infectious viruses. Our results
with the H171A substitution demonstrate a similar high pH of
fusion phenotype, as alanine will not be capable of forming the
equivalent hydrogen bonds to the fusion peptide or the H181
carbonyl oxygen. In all probability, this loss of hydrogen bonds
is responsible for the reduced stability of the mutant HA. By
contrast, substitution of tyrosine for HA1 His 17 led to a
reduction by 0.3 of the pH at which conformational changes and
membrane fusion were detected. Modelling of tyrosine at this
position and structural comparisons with the HAs of H1 group
subtypes indicate that the longer side chain could allow the
hydroxyl group to form hydrogen bonds directly to residues 10
and 12 of the fusion peptide (Fig. 7). Presumably, these direct
bonds would be stronger than those formed via water when
histidine is present at HA1 position 17, thus helping to account
for the increased stability of the H171Y mutant. In addition,
unlike histidine, tyrosine at this position would not have the
potential to change protonation state at a pH relevant for fusion.
These results suggest that for H3 group HAs, protonation of the
histidine at HA1 position 17 is involved in the activation of
membrane fusion.
Substitutions at HA2 position 111 resulted in elevated fusion
pH, by 0.6 for T1112H, 0.3 for T1112V, and 0.1 for T1112A,
which suggests that this residue is also significant for the
stability of the neutral pH structure. The identity of the residue
at HA2 position 111 appears to dictate in part the group-specific
412 S. Thoennes et al. / Virology 370 (2008) 403–414structure of a four-residue complex composed of HA2 111, HA1
18, HA1 38, and HA2 Trp 21 (Russell et al., 2004). The
orientation of the side chains of HA2 Trp 21 and HA1 18 is
quite different depending on whether HA2 111 is threonine, as
in the H3 group HAs, or histidine, as found in the H1 group
(Fig. 8). In HAs of the H3 group, the Trp 21 and His 18 side
chains are aligned with one another and oriented side-on
towards Thr 111, and HA1 His 17 is positioned with the face of
the imidazole directed toward Thr 111. In the H1 group HAs,
Trp 21 is located such that the indole side chain faces and
completely buries the histidine at HA2 position 111. In these
structures, the HA1 His 18 side chain orients away from HA2
His 111. The structural differences in this region could indicate
group-specific mechanisms for initiating fusion, and it is
possible that protonation of HA2 His 111 may play a role
similar to that suggested by our results for HA1 His 17 of H3
HA as a potential trigger residue. Our initial efforts to explore
this possibility by mutagenesis of HA2 His 111 in the H2
subtype HA of A/Japan/305/57 virus have been inconclusive, as
all single amino acid substitution mutants examined thus far fail
to express on the cell surface in the native HA conformation
(data not shown).
Another indication that residues in this region of HA have
evolved in coordinate fashion derives from our analysis of
multiple mutants. For a number of these, it is difficult to
interpret the consequences for fusion of compound changes due
to structural aberrations of the expressed proteins, which sug-
gests that the cumulative effects of two or more changes in this
region decrease HA stability to an extent that the proteins are
misfolded or their conformations are altered during transport to
the cell surface. Among the multiple mutants that expressed on
cell surfaces appropriately, the results of mutants containing
H1062A and T1112Awere notable. Expressed individually, each
mutation caused an increase in fusion pH of 0.1, and when
expressed together, the double mutant (H1062A, T1112A)Fig. 8. Overlapping structural representation of H1 (green) and H3 (blue)
subtype HAs in the region of HA1 residue 17 and HA2 residue 111. The location
and side chain orientation of nearby residues HA1 18, HA1 38, and HA2 21 are
positioned characteristically dependent on the residues present at HA1 17 and
HA2 111. The HA2 N-terminus is indicated by the red balls.resulted in an increase in the pH of conformational change of
0.4 relative to WT. However, as components of a triple mutant
containing the H171Y change, the pH of structural transition
was nearly indistinguishable from WT. These results are
consistent with observations on the stabilizing effects of the
H171Y mutation and the additive contributions of mutations
within localized regions (Steinhauer et al., 1996).
Overall, the results presented here are compatible with the
observation that the amino acids at positions HA1 17 and HA2
111 have segregated as a unit during evolution due to functional
compatibility. Perhaps HA1 His 17 plays a role in the initial
trigger for membrane fusion of H3 group HAs, and in the H1
group HAs that have tyrosine at HA1 17, the histidine at HA2
111 plays a similar role. Initial structural perturbations involving
these residues may alter the chemical environment of additional
residues initiating a cascade of molecular transitions involving
structural intermediates (Bottcher et al., 1999; Korte et al., 1999,
1997; Puri et al., 1990; Remeta et al., 2002). Secondary trigger
residues or stabilizing mutations elsewhere in the HA trimer
(Godley et al., 1992; Hoffman et al., 1997; Kemble et al., 1992;
Steinhauer et al., 1991a) may modulate the relative stability of
structural intermediates or regulate transitional “checkpoints”. A
greater appreciation of the mechanisms by which the confor-
mational changes of HA are triggered and the structural
intermediates involved should aid in the further design and
development of anti-influenza drugs that inhibit fusion (Bodian
et al., 1993; Cianci et al., 1999; Combrink et al., 2000; Hoffman
et al., 1997; Luo et al., 1997; Yu et al., 1999).
Materials and methods
Mutagenesis and expression of HAs
The HA cDNA from the H3N2 subtype virus A/Aichi/2/68
was mutated by site-directed mutagenesis using a QuickChange
mutagenesis kit (Stratagene). The presence of the desired
mutations and the absence of extraneous mutations were
confirmed by nucleotide sequencing of entire HA coding
regions. The mutant cDNAs were expressed as recombinant
vaccinia viruses using the plaque-selection system (Blasco and
Moss, 1995). The generated viruses were propagated on CV1
cells in Dulbecco's modified Eagle's medium supplemented
with 10% fetal calf serum.
Cell surface expression
HA cell surface expression was analyzed using a trypsin
cleavage assay with recombinant vaccinia-infected CV1 cells as
described previously (Steinhauer et al., 1995) with a few
modifications. The only difference is that blots were developed
using chemiluminescence rather than radiolabeled second
antibody. Following electrophoresis, blots were incubated with
anti-HA rabbit polyclonal rabbit serum, washed, then incubated
with a Protein A-HRP conjugate (Sigma cat# P8651). Blots were
developed with the Enhanced Chemiluminescence Reagent
(Amersham Pharmacia) according to the manufacturer's instruc-
tions. Quantitative cell surface expression by ELISAwas carried
413S. Thoennes et al. / Virology 370 (2008) 403–414out on recombinant vaccinia virus-infected HA-expressing
HeLa cells using a panel of monoclonal antibodies that recog-
nize distinct antigenic regions of wild-type HA as described
(Steinhauer et al., 1991b).
Conformational change assays
Trypsin susceptibility
Recombinant vaccinia virus-infected CV1 cells were used
for trypsin susceptibility assays to determine the pH of con-
formational changes for WT and mutant HAs. Approximately
24 h post-infection, HA-expressing infected cells were treated
with trypsin (Sigma) at 5 μg/ml, 10 min, 37 °C, washed, and
incubated at various pH values for 5 min at 37 °C. The medium
was then returned to neutral pH and the monolayer was incu-
bated in the presence of trypsin (5 μg/ml) for 30 min at 37 °C.
The reaction was stopped by the addition of soybean trypsin
inhibitor (Sigma) at a final concentration of 5 μg/ml. Subse-
quently, the cells were washed with PBS, and lysates were
analyzed following SDS–PAGE under reducing conditions by
immunoblot assay using anti-HA rabbit polyclonal primary
antibody and a Protein A-HRP conjugate. Blots were developed
using ECL, and intensities of HA1 and HA2 bands were
quantified on VersaDoc Imaging System (Bio-Rad) with the
Quantity One analysis software.
ELISA
Conformation change analysis by ELISA was performed on
recombinant vaccinia-infected HeLa cell monolayers as de-
scribed (Steinhauer et al., 1991b) using monoclonal antibodies
HC3 and HC67. HC3 recognizes both native and low pH HA,
while HC67 recognizes only the native conformation.
Fusion assay
The pH of membrane fusion was assayed by polykaryon
formation as described previously (Li et al., 2006; Steinhauer
et al., 1991b), except that the pH was reduced for 30 s.
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